PubMed Health⌕ Search

Biomedical subjects

G Knappe

Publications and source records attributed to G Knappe.

At least 37 records · Page 2Linked to original sources
PubMed1984

[Correlation between the morphological and functional parameters in hypophyseal adenomas of acromegalic patients].

A series of 50 human pituitary adenomas with acromegaly has been investigated morphologically and densitometrically by use of a system for automated microscope picture analysis (AMBA). Twenty nuclear and tissue features have been measured. The tumors were divided into eosinophilic, eosinophilic/chromophobe and chromophobe adenomas. We found no correlation between the analysed karyometric features and the blood hormone levels. But considering the results of the hematoxylin-eosin-staining, significant differences exist between the three histological subtypes. Eosinophilic adenomas show higher blood hormone levels than mixed and chromophobe tumors. Significant differences between the subtypes in some nuclear and tissue features allow a classification. Eosinophilic adenomas have bigger nuclei with higher extinction (that means higher DNA-content). The parameter EXTK (expected extinction at the borderline of the nuclei) was of great importance for the separation of mixed and chromophobe adenomas. The size of the adenomas had no influence on the blood hormone levels. Further studies are necessary to answer the question whether these results are a true expression of a different functional state.

Acromegaly↗
PubMed1983

[Automated morphometric and densitometric studies of pituitary adenomas].

A set of 131 pituitary adenomas has been investigated morphometrically and densitometrically by use of a system for automatical microscope picture analysis (AMPA). About 500 nuclei per adenoma have been scanned for estimating 20 nuclear and tissue parameters (5 and 10 min per adenoma). Endocrine inactive adenomas differ significantly by some parameters from active adenomas. The cell nuclei of inactive tumors are smaller, of more spherical and have higher extinction values on an average. The nuclei of adenomas from patients with Cushing's syndrome differ from the nuclei of prolactinomas and acromegalics because of their lower similarity to spheres. We found no correlation between the nuclear and tissue parameters analyzed in this study and the blood hormone levels.

Acromegaly↗
PubMed1982

[Clinical value of a sensitive TSH-RIA].

Based on a sensitive TSH-RIA (measuring-range 0.2-25 mU/l, 50%-intercept 2 mU/l, coefficients of between-assay-variation 5-10%) and on nearly 1200 cases, it is demonstrated that clinical results can be received by determination of basal serum-TSH alone. Values above 0.5 mU TSH/l indicate positive TRH-tests in a good correlation between increasing basal concentrations and pituitary TSH-reserve. TSH-levels below 0.3 mU/l proceed with negative TRH-tests. In selected healthy subjects, we found all TSH-values between 0.7 and nearly 5 mU/l (means = 1.99). In euthyroid goiters, TSH-levels are normally in the same range, but in nodular goiters, subnormal values were found accumulated. TSH-levels below 0.3 mU/l are helpful to discover non-suppressibility. Hormone-treatment of goiters is successful above all in case of high-normal pretherapeutic TSH-values. "Fine-tuning" of hormone-dosage (goiter-treatment, postoperative prophylaxis, suppression-therapy in thyroid carcinoma) as well as monitoring of thyrotoxicosis-treatment is recommended to be performed by means of basal TSH-determination. In pituitary disorders, thyroid hormone-treatment seems to be necessary only at TSH-levels below 0.5 mU/l. Combination of basal TSH and total T-3 is economical and describes nearly all functional situations in diagnosis and treatment of thyroid diseases.

Goiter↗
PubMed1979

[Hypogonadism in the male].

The hypogonadism of man and its causes are described in short form. A scheme of the gradual diagnostics explains the possibilities of the diagnostic approach. At the same time is dealt with the therapeutic measures and their indications.

Androgens↗
PubMed1979

[Androgen secreting adrenal cortex tumors].

Endokrine active tumours of the adrenal cortex are rare diseases in man. Benign as well as malignant tumours of the adrenal cortex can alone excrete cortisol, aldosterone, androgens or oestrogens. More frequent are, however, tumours with a mixed incretion. Publications about tumours forming sexual hormones are above all descriptions of individual cases. After a short explanation of the most important clinical, diagnostic and therapeutic aspects on androgen-producing tumours of the adrenal cortex four own cases are discussed.

Adrenal Cortex Neoplasms↗
PubMed1977

[Determination of 11-hydroxycorticosteroids in stress-evoking interventions as an endocrinological test].

Determinations of the 11-hydroxycorticosteroids (11-OHCS) in intervention evoking stress proved as advantageous method for the estimation of the ACTH-reserve. After pneumencephalography or transethmoidal-transsphenoidal operations of the hypophysis intensive increase of 11-OHCS in the plasma and urine were observed, when the ACTH-reserve was intact. The investigations give the possibility of renouncing additional special functional tests.

11-Hydroxycorticosteroids↗
PubMed1975

Total and free testosterone in plasma of hypo- and agonadal men.

Plasma total testosterone (T), apparently free T and testosterone binding globulin (TeBG) capacity determined in 14 normal men aged 30-40 years were 461 +/- 100 ng/100 ml, 9.4 +/- 3.0 ng/100 ml and 5.7 +/- 1.9 X 10(-8) M, respectively, whereas in 16 hypogonadal men the corresponding values were 38.6 +/- 27.2 ng/100 ml, 0.47 +/- 0.41 ng/100 ml and 10.4 +/- 3.4 X 10(-8) M showing the TeBG capacity significantly higher (p less than 0.001) in hypogonadal than in normal men. Treatment of 5 hypogonadal subjects with 250 mg testosterone enanthate plus 50 mg testosterone propionate decreased (p less than 0.001) the TeBG level from 14.7 +/- 2.5 X 10(-8YM to 8.3 +/- 1.4 X 10(-8) M on day 8 after a single injection. According to this difference in TeBG, the free T fraction in plasma rose from 0.94% to 1.9% of the total T concentration. These results suggest that alteration of total plasma T affected the TeBG capacity. Decreased T levels raised and increased T concentrations suppressed TeBG, but with a delayed response to the changed T concentrations. The initial mean values in 12 patients with prostatic cancer aged 60-74 years were 397 +/- 165 ng/100 ml, 4.05 +/- 1.8 ng/100 ml and 11.9 +/- 3.3 X 10(-8) M, respectively. The TeBG capacity in these patients was significantly higher and the free T concentration significantly lower (p less than 0.001) than those of the younger normal males. After treatment with 12 g diethylstilbestrol diphosphate and orchidectomy, the TeBG increased to 33.3 +/- 13.1 X 10(-8) M and the plasma free T concentration decreased to the minimal value of 0.053 +/- 0.04 ng/100 ml.

Adult↗